Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: We agree with the proposal of Dr Eisenstein and colleagues1 for a 3-group clinical trial based on the duration of clopidogrel therapy to further investigate the role of dual anticoagulation with clopidogrel and aspirin following DES implantation. In addition, it might be worthwhile to further analyze patients in “ideal” and “real life” subgroups.
Khurana A, Vinayek N. Clopidogrel and Long-term Outcomes After Drug-Eluting Stent Implantation. JAMA. 2007;297(16):1769-1771. doi:10.1001/jama.297.16.1769-b